These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 34831057)

  • 1. Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies.
    Jin Q; Ma RCW
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications.
    Cai D; Hou B; Xie SL
    Amino Acids; 2023 May; 55(5):563-578. PubMed ID: 37067568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics of Type 1 and Type 2 Diabetes.
    Arneth B; Arneth R; Shams M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
    Wang N; Zhu F; Chen L; Chen K
    Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics applied to the discovery of tuberculosis and diabetes mellitus biomarkers.
    Salgado-Bustamante M; Rocha-Viggiano AK; Rivas-Santiago C; Magaña-Aquino M; López JA; López-Hernández Y
    Biomark Med; 2018 Sep; 12(9):1001-1013. PubMed ID: 30043640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics and Proteomics in Type 2 Diabetes.
    Chen ZZ; Gerszten RE
    Circ Res; 2020 May; 126(11):1613-1627. PubMed ID: 32437301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Signatures in Type 2 Diabetes: A Systematic Review and Integrative Analysis.
    Sun Y; Gao HY; Fan ZY; He Y; Yan YX
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31782507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
    Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
    Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Metabolomic Patterns in Type 2 Diabetes Mellitus and Response to Glucose-Lowering Medications-Review.
    Shahisavandi M; Wang K; Ghanbari M; Ahmadizar F
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
    Abu Bakar MH; Sarmidi MR; Cheng KK; Ali Khan A; Suan CL; Zaman Huri H; Yaakob H
    Mol Biosyst; 2015 Jul; 11(7):1742-74. PubMed ID: 25919044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics in diabetic complications.
    Filla LA; Edwards JL
    Mol Biosyst; 2016 Apr; 12(4):1090-105. PubMed ID: 26891794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Metabolomics in Diabetes Management with Traditional Chinese Medicine: A Review.
    He Y; Zhang H; Yang Y; Yu X; Zhang X; Xing Q; Zhang G
    Am J Chin Med; 2021; 49(8):1813-1837. PubMed ID: 34961417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics.
    Vasishta S; Ganesh K; Umakanth S; Joshi MB
    Metabolomics; 2022 Jun; 18(7):45. PubMed ID: 35763080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics of Type 1 and Type 2 Diabetes: Insights into Risk Prediction and Mechanisms.
    Izundegui DG; Nayor M
    Curr Diab Rep; 2022 Feb; 22(2):65-76. PubMed ID: 35113332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics in human type 2 diabetes research.
    Lu J; Xie G; Jia W; Jia W
    Front Med; 2013 Mar; 7(1):4-13. PubMed ID: 23377891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome.
    Roberts LD; Koulman A; Griffin JL
    Lancet Diabetes Endocrinol; 2014 Jan; 2(1):65-75. PubMed ID: 24622670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.
    Yousri NA; Suhre K; Yassin E; Al-Shakaki A; Robay A; Elshafei M; Chidiac O; Hunt SC; Crystal RG; Fakhro KA
    Diabetes; 2022 Feb; 71(2):184-205. PubMed ID: 34732537
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.